A game-changing NHS AI blood test is set to revolutionize the diagnosis of womb cancer in England's hospitals. The test uses artificial intelligence to analyze a woman's blood for signs of cancer before an invasive check is carried out, potentially saving lives.
According to estimates, around 90,000 postmenopausal women are referred by general practitioners each year to undergo further testing after experiencing heavy bleeding. Of these, about 10,000 will be diagnosed with womb cancer annually, although the actual number may be higher due to underdiagnosis and misdiagnosis. To address this issue, NHS hospitals in England are preparing to use the AI blood test, which is being developed by a team at Imperial College London.
The AI-powered blood test has the potential to significantly reduce the number of invasive womb cancer checks required. By identifying women with mild or borderline cases before they require more extensive testing, doctors may be able to prevent unnecessary surgery and radiation treatments, ultimately saving lives. The NHS AI blood test is just one example of how technology is being harnessed in innovative ways to improve patient care and outcomes.